| Updated on July 14, 2016 Published on July 14, 2016

Cadila Healthcare Ltd has informed BSE that Companys US based 100% subsidiary company Zydus Pharmaceuticals (USA) Inc. (Zydus) will begin informing on July 12, 2016 its customers that Zydus will start selling an authorized generic of Asacol HD (mesalamine delayed - release tablets 800 mg) in the United States commencing on August 01, 2016.

Source : BSE - >www.bseindia.com

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on July 14, 2016
This article is closed for comments.
Please Email the Editor